Publications by authors named "Mohammad Haman"

Claim this Profile
F
First-line sunitinib for metastatic renal cell carcinoma, a 15-year single institution real-world evidence study.
Mohammad Haman, Johanne Ahrenfeldt, Iben Lyskjær, Niels Fristrup

Urol Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis